UCH-L3在上皮性卵巢癌中的表达及临床意义
UCH-L3 Expression in Epithelial Ovarian Cancer and Its Clinical Significance
-
摘要:目的 了解泛素羧基末端水解酶3(UCH-L3)在上皮性卵巢癌(EOC)组织中的表达,分析UCH-L3与EOC患者的临床病理特征及预后的关系。方法 通过免疫组化染色方法检测不同卵巢组织中UCH-L3的表达,包括正常卵巢组织20例(正常卵巢组)、上皮性卵巢肿瘤组织26例(良性卵巢肿瘤组)、交界性上皮性卵巢肿瘤组织22例(交界性卵巢肿瘤组)、EOC组织61例(EOC组),分析UCH-L3的表达与EOC患者临床特征及预后的关系。结果 UCH-L3在EOC组卵巢组织中的表达高于良性卵巢肿瘤组和正常卵巢组(P均<0.05)。UCH-L3在EOC中的FIGO晚期组、分化程度高级别组、有腹腔内转移组中的表达高于FIGO早期组(P=0.006)、分化程度低级别组(P=0.001)和无腹腔内转移组(P=0.032)。UCH-L3在EOC患者肿瘤组织高、低表达组间的生存时间差异无统计学意义。结论 UCH-L3在EOC发生发展中可能有一定作用,但与患者的预后无关。Abstract:Objective To study the expression of ubiquitin C-terminal hydrolase-L3 (UCH-L3) in epithelial ovarian cancer (EOC) tissues, and to analyze the relationship between UCH-L3 expression and the clinic pathological characteristics and prognosis of EOC patients.Methods Immunohistochemical analysis was performed to evaluate UCH-L3 expression in different ovarian epithelial tissue specimens. The correlation between UCH-L3 expression and clinical pathologic parameters, prognosis and of EOC was statistically analyzed.Results The expression level of UCH-L3 in EOC was higher than that in benign ovarian tumor and normal ovary (P < 0.05). The positive expression level of UCH-L3 in late FIGO group, high-level group, group with intraperitoneal metastasis were significantly higher than that in early FIGO group (P=0.006), low-level group (P=0.001), group without intraperitoneal metastasis (P=0.032). There was no significant difference in survival time between the high and low expression groups of UCH-L3.Conclusion UCH-L3 may play a role in EOC pathogenesis and progression.
© 2019 《koko体育app
学报(医学版)》编辑部 版权所有
开放获取♊ 本文遵循知识共享署名—非商业性使用4.0国际许可协议(CC BY-NC 4.0),允许第三方对本刊发表的论文自由共享(即在任何媒介以任何形式复制、发行原文)、演绎(即修改、转换或以原文为基础进行创作),必须给出适当的署名,提供指向本文许可协议的链接,同时标明是否对原文作了修改;不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问